Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sangene Biosciences, commonly known as SangeneBio, is a specialized contract research organization (CRO) and biotechnology firm headquartered in Bangalore, India. Established in 2004, the company provides a comprehensive suite of R&D services, including molecular biology, protein chemistry, microbiology, and cell culture. SangeneBio is particularly recognized for its expertise in recombinant protein expression, monoclonal antibody development, and advanced analytical testing such as HPLC and NGS. The company serves a global clientele across the pharmaceutical, biotechnology, and academic sectors, supporting various phases of the drug discovery pipeline. In addition to its research activities, SangeneBio operates a well-regarded training division that offers industrial exposure and technical skills to the next generation of biotech researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SangeneBio.